Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine–D-Alanine Ligase With a Novel Inhibitor, IMB-0283
The emergence of drug-resistant Mycobacterium tuberculosis (Mtb) has hampered treatments for tuberculosis, which consequently now require novel agents to overcome such drug resistance. The genetically stable D-alanine–D-alanine ligase A (DdlA) has been deemed as an excellent therapeutic target for t...
Main Authors: | Jianzhou Meng, Peng Gao, Xiao Wang, Yan Guan, Yishuang Liu, Chunling Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.03017/full |
Similar Items
-
The Biological Properties and Potential Interacting Proteins of d-Alanyl-d-alanine Ligase A from Mycobacterium tuberculosis
by: Shufeng Yang, et al.
Published: (2018-02-01) -
Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae
by: Stefania eDe Benedetti, et al.
Published: (2014-02-01) -
Plasmid to generate Mycobacteria mutants
by: Qi Deng, et al.
Published: (2018-02-01) -
Deficiency of D‐alanyl‐D‐alanine ligase A attenuated cell division and greatly altered the proteome of Mycobacterium smegmatis
by: Yingfei Chen, et al.
Published: (2019-09-01) -
A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus
by: Miriam Moscoso, et al.
Published: (2018-12-01)